Trial intelligence / Profile preview

Mefenamic Acid vs Tranexamic Acid for AUB

NCT06369012Completed

Sponsor
Egymedicalpedia
Start
Mar 2024
Primary completion
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial in abnormal uterine bleeding (AUB) comparing Mefenamic Acid with Tranexamic Acid (2 arms). Primary endpoint: Bleeding Control at 1 week. Started Mar 2024; status: completed.

02

Drugs

Mefenamic acidtranexamic acid
03

Conditions

abnormal uterine bleeding (AUB)

Beyond the preview

Go deeper on NCT06369012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06369012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call